Table 4.
Prioritizing Treatment Options for SCLC
| Clinical Scenario | Treatment Recommendation | Initial Delay, wk | Workup | Comments |
|---|---|---|---|---|
| Limited Stage | ||||
| Untreated | Concurrent chemotherapy and radiotherapy | <2 | standard | if radiation therapy is not available start with chemotherapy and add XRT as early as possible |
| On treatment | Concurrent chemotherapy and radiotherapy followed by chemotherapy | <2 | standard | continue with CCRT, keep cycles of chemotherapy to 4, use growth factors away from XRT |
| Completed treatment | PCI | 2–8 | standard | |
| Observation | >8 | may delay imaging for a mo | Flow up by teleclinic | |
| Extensive Stage | ||||
| Untreated | Chemotherapy | <2 | standard | should start on time. Consider growth factors or dose reduction, consider oral etoposide for d 2 and 3 |
| Chemotherapy and immunotherapy | <2 | standard | Be selective | |
| On treatment | chemotherapy | <2 | may extend assessment for 3 cycles if stable | |
| Chemotherapy and immunotherapy | <2 | |||
| Completed treatment | Observation | 2–8 | May extend up to 2 mo | if asymptomatic by teleclinic |
CCRT, concurrent chemoradiation therapy; PCI, prophylactic cranial irradiation; XRT, radiation therapy.